SCHEMBL26243113

SCHEMBL26243113

CCN(CCC(C)C)CC1CCCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
LMNA P02545 3/20 0.36
MAPT P10636 1/20 0.36
HTR2A P28223 7/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
CYP3A4 P08684 3/20 0.33
KDM4E B2RXH2 2/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A4 P31645 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33
KCNH2 Q12809 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
RORC P51449 1/20 0.32
PER2 O15055 1/20 0.32
CRY1 Q16526 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12039810 0.92 ALDH1A1 (0.49) ALDH1A1LMNAMAPTMEN1KMT2A
SCHEMBL23969731 0.83 LMNA (0.47) ALDH1A1LMNAMAPTHTR2AMEN1
SCHEMBL21127002 0.82 ALDH1A1 (0.47) ALDH1A1LMNAMAPTKMT2AKDM4E
SCHEMBL26239730 0.79 ALDH1A1 (0.40) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL10965080 0.79 ALDH1A1 (0.40) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL10175373 0.77 ALDH1A1 (0.42) ALDH1A1LMNAMAPTKMT2AKDM4E
SCHEMBL10175378 0.77 ALDH1A1 (0.42) ALDH1A1LMNAMAPTKMT2AKDM4E
SCHEMBL15865805 0.75 ALDH1A1 (0.53) ALDH1A1LMNAMAPTKMT2AKDM4E
SCHEMBL17425077 0.73 PLA2G1B (0.31) CYP1A2CYP2D6
SCHEMBL25663981 0.73 ALDH1A1 (0.40) ALDH1A1LMNAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753403-B2 EIF4E inhibitors and uses thereof PIC Therapeutics, Inc. (US) 2023-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11753403-B2 EIF4E inhibitors and uses thereof EIF4E, EIF4EBP1, EIF4A1 ALDH1A1 4776/4885LMNA 2647/4885MAPT 2231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.